0001415889-24-019279.txt : 20240703 0001415889-24-019279.hdr.sgml : 20240703 20240703193542 ACCESSION NUMBER: 0001415889-24-019279 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240702 FILED AS OF DATE: 20240703 DATE AS OF CHANGE: 20240703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Whiting Samuel CENTRAL INDEX KEY: 0001870373 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35890 FILM NUMBER: 241101340 MAIL ADDRESS: STREET 1: C/O TEMPEST THERAPEUTICS, INC. STREET 2: 7000 SHORELINE COURT, SUITE 275 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tempest Therapeutics, Inc. CENTRAL INDEX KEY: 0001544227 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 451472564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 400 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 415-798-8589 MAIL ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 400 CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: Millendo Therapeutics, Inc. DATE OF NAME CHANGE: 20181207 FORMER COMPANY: FORMER CONFORMED NAME: OvaScience, Inc. DATE OF NAME CHANGE: 20120308 4 1 form4-07032024_110739.xml X0508 4 2024-07-02 0001544227 Tempest Therapeutics, Inc. TPST 0001870373 Whiting Samuel C/O TEMPEST THERAPEUTICS, INC. 2000 SIERRA POINT PARKWAY, SUITE 400 BRISBANE CA 94005 false true false false Chief Medical Officer 0 Common Stock 2024-07-02 4 P 0 4672 2.13 A 9573 D Includes 3,000 shares acquired under the Issuer's stock purchase plan. /s/ Nicholas Maestas, Attorney-in-Fact 2024-07-03